▶ 調査レポート

リラグルチド注射の世界市場(~2026年)

• 英文タイトル:Global Liraglutide Injection Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。リラグルチド注射の世界市場(~2026年) / Global Liraglutide Injection Market Insights and Forecast to 2026 / MRC2-11QY07300資料のイメージです。• レポートコード:MRC2-11QY07300
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、116ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はリラグルチド注射のグローバル市場について調査・分析したレポートです。種類別(タイプI、タイプII)市場規模、用途別(低血糖、体重減少、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別リラグルチド注射の競争状況、市場シェア
・世界のリラグルチド注射市場:種類別市場規模 2015年-2020年(タイプI、タイプII)
・世界のリラグルチド注射市場:種類別市場規模予測 2021年-2026年(タイプI、タイプII)
・世界のリラグルチド注射市場:用途別市場規模 2015年-2020年(低血糖、体重減少、その他)
・世界のリラグルチド注射市場:用途別市場規模予測 2021年-2026年(低血糖、体重減少、その他)
・北米のリラグルチド注射市場分析:米国、カナダ
・ヨーロッパのリラグルチド注射市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのリラグルチド注射市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のリラグルチド注射市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのリラグルチド注射市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Novo Nordisk
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Liraglutide Injection Market
The global Liraglutide Injection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Liraglutide Injection Scope and Market Size
Liraglutide Injection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Liraglutide Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Liraglutide Injection market is segmented into
Type I
Type II

Segment by Application, the Liraglutide Injection market is segmented into
Hypoglycemic
Weight Lose
Others

Regional and Country-level Analysis
The Liraglutide Injection market is analysed and market size information is provided by regions (countries).
The key regions covered in the Liraglutide Injection market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Liraglutide Injection Market Share Analysis
Liraglutide Injection market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Liraglutide Injection business, the date to enter into the Liraglutide Injection market, Liraglutide Injection product introduction, recent developments, etc.

The major vendors covered:
Novo Nordisk

レポート目次

1 Study Coverage
1.1 Liraglutide Injection Product Introduction
1.2 Market Segments
1.3 Key Liraglutide Injection Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Liraglutide Injection Market Size Growth Rate by Type
1.4.2 Type I
1.4.3 Type II
1.5 Market by Application
1.5.1 Global Liraglutide Injection Market Size Growth Rate by Application
1.5.2 Hypoglycemic
1.5.3 Weight Lose
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Liraglutide Injection Market Size, Estimates and Forecasts
2.1.1 Global Liraglutide Injection Revenue 2015-2026
2.1.2 Global Liraglutide Injection Sales 2015-2026
2.2 Global Liraglutide Injection, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Liraglutide Injection Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Liraglutide Injection Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Liraglutide Injection Competitor Landscape by Players
3.1 Liraglutide Injection Sales by Manufacturers
3.1.1 Liraglutide Injection Sales by Manufacturers (2015-2020)
3.1.2 Liraglutide Injection Sales Market Share by Manufacturers (2015-2020)
3.2 Liraglutide Injection Revenue by Manufacturers
3.2.1 Liraglutide Injection Revenue by Manufacturers (2015-2020)
3.2.2 Liraglutide Injection Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Liraglutide Injection Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Liraglutide Injection Revenue in 2019
3.2.5 Global Liraglutide Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Liraglutide Injection Price by Manufacturers
3.4 Liraglutide Injection Manufacturing Base Distribution, Product Types
3.4.1 Liraglutide Injection Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Liraglutide Injection Product Type
3.4.3 Date of International Manufacturers Enter into Liraglutide Injection Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Liraglutide Injection Market Size by Type (2015-2020)
4.1.1 Global Liraglutide Injection Sales by Type (2015-2020)
4.1.2 Global Liraglutide Injection Revenue by Type (2015-2020)
4.1.3 Liraglutide Injection Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Liraglutide Injection Market Size Forecast by Type (2021-2026)
4.2.1 Global Liraglutide Injection Sales Forecast by Type (2021-2026)
4.2.2 Global Liraglutide Injection Revenue Forecast by Type (2021-2026)
4.2.3 Liraglutide Injection Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Liraglutide Injection Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Liraglutide Injection Market Size by Application (2015-2020)
5.1.1 Global Liraglutide Injection Sales by Application (2015-2020)
5.1.2 Global Liraglutide Injection Revenue by Application (2015-2020)
5.1.3 Liraglutide Injection Price by Application (2015-2020)
5.2 Liraglutide Injection Market Size Forecast by Application (2021-2026)
5.2.1 Global Liraglutide Injection Sales Forecast by Application (2021-2026)
5.2.2 Global Liraglutide Injection Revenue Forecast by Application (2021-2026)
5.2.3 Global Liraglutide Injection Price Forecast by Application (2021-2026)

6 North America
6.1 North America Liraglutide Injection by Country
6.1.1 North America Liraglutide Injection Sales by Country
6.1.2 North America Liraglutide Injection Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Liraglutide Injection Market Facts & Figures by Type
6.3 North America Liraglutide Injection Market Facts & Figures by Application

7 Europe
7.1 Europe Liraglutide Injection by Country
7.1.1 Europe Liraglutide Injection Sales by Country
7.1.2 Europe Liraglutide Injection Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Liraglutide Injection Market Facts & Figures by Type
7.3 Europe Liraglutide Injection Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Liraglutide Injection by Region
8.1.1 Asia Pacific Liraglutide Injection Sales by Region
8.1.2 Asia Pacific Liraglutide Injection Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Liraglutide Injection Market Facts & Figures by Type
8.3 Asia Pacific Liraglutide Injection Market Facts & Figures by Application

9 Latin America
9.1 Latin America Liraglutide Injection by Country
9.1.1 Latin America Liraglutide Injection Sales by Country
9.1.2 Latin America Liraglutide Injection Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Liraglutide Injection Market Facts & Figures by Type
9.3 Central & South America Liraglutide Injection Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Liraglutide Injection by Country
10.1.1 Middle East and Africa Liraglutide Injection Sales by Country
10.1.2 Middle East and Africa Liraglutide Injection Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Liraglutide Injection Market Facts & Figures by Type
10.3 Middle East and Africa Liraglutide Injection Market Facts & Figures by Application

11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Liraglutide Injection Products Offered
11.1.5 Novo Nordisk Related Developments
11.1 Novo Nordisk
11.1.1 Novo Nordisk Corporation Information
11.1.2 Novo Nordisk Description and Business Overview
11.1.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Novo Nordisk Liraglutide Injection Products Offered
11.1.5 Novo Nordisk Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Liraglutide Injection Market Estimates and Projections by Region
12.1.1 Global Liraglutide Injection Sales Forecast by Regions 2021-2026
12.1.2 Global Liraglutide Injection Revenue Forecast by Regions 2021-2026
12.2 North America Liraglutide Injection Market Size Forecast (2021-2026)
12.2.1 North America: Liraglutide Injection Sales Forecast (2021-2026)
12.2.2 North America: Liraglutide Injection Revenue Forecast (2021-2026)
12.2.3 North America: Liraglutide Injection Market Size Forecast by Country (2021-2026)
12.3 Europe Liraglutide Injection Market Size Forecast (2021-2026)
12.3.1 Europe: Liraglutide Injection Sales Forecast (2021-2026)
12.3.2 Europe: Liraglutide Injection Revenue Forecast (2021-2026)
12.3.3 Europe: Liraglutide Injection Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Liraglutide Injection Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Liraglutide Injection Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Liraglutide Injection Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Liraglutide Injection Market Size Forecast by Region (2021-2026)
12.5 Latin America Liraglutide Injection Market Size Forecast (2021-2026)
12.5.1 Latin America: Liraglutide Injection Sales Forecast (2021-2026)
12.5.2 Latin America: Liraglutide Injection Revenue Forecast (2021-2026)
12.5.3 Latin America: Liraglutide Injection Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Liraglutide Injection Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Liraglutide Injection Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Liraglutide Injection Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Liraglutide Injection Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Liraglutide Injection Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Liraglutide Injection Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Liraglutide Injection Market Segments
Table 2. Ranking of Global Top Liraglutide Injection Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Liraglutide Injection Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of Type I
Table 5. Major Manufacturers of Type II
Table 6. Global Liraglutide Injection Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 7. Global Liraglutide Injection Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 8. Global Liraglutide Injection Sales by Regions 2015-2020 (K Pcs)
Table 9. Global Liraglutide Injection Sales Market Share by Regions (2015-2020)
Table 10. Global Liraglutide Injection Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Liraglutide Injection Sales by Manufacturers (2015-2020) (K Pcs)
Table 12. Global Liraglutide Injection Sales Share by Manufacturers (2015-2020)
Table 13. Global Liraglutide Injection Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Liraglutide Injection by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liraglutide Injection as of 2019)
Table 15. Liraglutide Injection Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Liraglutide Injection Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Liraglutide Injection Price (2015-2020) (USD/Pcs)
Table 18. Liraglutide Injection Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Liraglutide Injection Product Type
Table 20. Date of International Manufacturers Enter into Liraglutide Injection Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Liraglutide Injection Sales by Type (2015-2020) (K Pcs)
Table 23. Global Liraglutide Injection Sales Share by Type (2015-2020)
Table 24. Global Liraglutide Injection Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Liraglutide Injection Revenue Share by Type (2015-2020)
Table 26. Liraglutide Injection Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 27. Global Liraglutide Injection Sales by Application (2015-2020) (K Pcs)
Table 28. Global Liraglutide Injection Sales Share by Application (2015-2020)
Table 29. North America Liraglutide Injection Sales by Country (2015-2020) (K Pcs)
Table 30. North America Liraglutide Injection Sales Market Share by Country (2015-2020)
Table 31. North America Liraglutide Injection Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Liraglutide Injection Revenue Market Share by Country (2015-2020)
Table 33. North America Liraglutide Injection Sales by Type (2015-2020) (K Pcs)
Table 34. North America Liraglutide Injection Sales Market Share by Type (2015-2020)
Table 35. North America Liraglutide Injection Sales by Application (2015-2020) (K Pcs)
Table 36. North America Liraglutide Injection Sales Market Share by Application (2015-2020)
Table 37. Europe Liraglutide Injection Sales by Country (2015-2020) (K Pcs)
Table 38. Europe Liraglutide Injection Sales Market Share by Country (2015-2020)
Table 39. Europe Liraglutide Injection Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Liraglutide Injection Revenue Market Share by Country (2015-2020)
Table 41. Europe Liraglutide Injection Sales by Type (2015-2020) (K Pcs)
Table 42. Europe Liraglutide Injection Sales Market Share by Type (2015-2020)
Table 43. Europe Liraglutide Injection Sales by Application (2015-2020) (K Pcs)
Table 44. Europe Liraglutide Injection Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Liraglutide Injection Sales by Region (2015-2020) (K Pcs)
Table 46. Asia Pacific Liraglutide Injection Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Liraglutide Injection Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Liraglutide Injection Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Liraglutide Injection Sales by Type (2015-2020) (K Pcs)
Table 50. Asia Pacific Liraglutide Injection Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Liraglutide Injection Sales by Application (2015-2020) (K Pcs)
Table 52. Asia Pacific Liraglutide Injection Sales Market Share by Application (2015-2020)
Table 53. Latin America Liraglutide Injection Sales by Country (2015-2020) (K Pcs)
Table 54. Latin America Liraglutide Injection Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Liraglutide Injection Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Liraglutide Injection Revenue Market Share by Country (2015-2020)
Table 57. Latin America Liraglutide Injection Sales by Type (2015-2020) (K Pcs)
Table 58. Latin America Liraglutide Injection Sales Market Share by Type (2015-2020)
Table 59. Latin America Liraglutide Injection Sales by Application (2015-2020) (K Pcs)
Table 60. Latin America Liraglutide Injection Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Liraglutide Injection Sales by Country (2015-2020) (K Pcs)
Table 62. Middle East and Africa Liraglutide Injection Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Liraglutide Injection Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Liraglutide Injection Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Liraglutide Injection Sales by Type (2015-2020) (K Pcs)
Table 66. Middle East and Africa Liraglutide Injection Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Liraglutide Injection Sales by Application (2015-2020) (K Pcs)
Table 68. Middle East and Africa Liraglutide Injection Sales Market Share by Application (2015-2020)
Table 69. Novo Nordisk Corporation Information
Table 70. Novo Nordisk Description and Major Businesses
Table 71. Novo Nordisk Liraglutide Injection Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 72. Novo Nordisk Product
Table 73. Novo Nordisk Recent Development
Table 74. Global Liraglutide Injection Sales Forecast by Regions (2021-2026) (K Pcs)
Table 75. Global Liraglutide Injection Sales Market Share Forecast by Regions (2021-2026)
Table 76. Global Liraglutide Injection Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 77. Global Liraglutide Injection Revenue Market Share Forecast by Regions (2021-2026)
Table 78. North America: Liraglutide Injection Sales Forecast by Country (2021-2026) (K Pcs)
Table 79. North America: Liraglutide Injection Revenue Forecast by Country (2021-2026) (US$ Million)
Table 80. Europe: Liraglutide Injection Sales Forecast by Country (2021-2026) (K Pcs)
Table 81. Europe: Liraglutide Injection Revenue Forecast by Country (2021-2026) (US$ Million)
Table 82. Asia Pacific: Liraglutide Injection Sales Forecast by Region (2021-2026) (K Pcs)
Table 83. Asia Pacific: Liraglutide Injection Revenue Forecast by Region (2021-2026) (US$ Million)
Table 84. Latin America: Liraglutide Injection Sales Forecast by Country (2021-2026) (K Pcs)
Table 85. Latin America: Liraglutide Injection Revenue Forecast by Country (2021-2026) (US$ Million)
Table 86. Middle East and Africa: Liraglutide Injection Sales Forecast by Country (2021-2026) (K Pcs)
Table 87. Middle East and Africa: Liraglutide Injection Revenue Forecast by Country (2021-2026) (US$ Million)
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Market Risks
Table 91. Main Points Interviewed from Key Liraglutide Injection Players
Table 92. Liraglutide Injection Customers List
Table 93. Liraglutide Injection Distributors List
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Liraglutide Injection Product Picture
Figure 2. Global Liraglutide Injection Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Liraglutide Injection Sales Market Share by Application in 2020 & 2026
Figure 6. Hypoglycemic
Figure 7. Weight Lose
Figure 8. Others
Figure 9. Liraglutide Injection Report Years Considered
Figure 10. Global Liraglutide Injection Market Size 2015-2026 (US$ Million)
Figure 11. Global Liraglutide Injection Sales 2015-2026 (K Pcs)
Figure 12. Global Liraglutide Injection Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Global Liraglutide Injection Sales Market Share by Region (2015-2020)
Figure 14. Global Liraglutide Injection Sales Market Share by Region in 2019
Figure 15. Global Liraglutide Injection Revenue Market Share by Region (2015-2020)
Figure 16. Global Liraglutide Injection Revenue Market Share by Region in 2019
Figure 17. Global Liraglutide Injection Sales Share by Manufacturer in 2019
Figure 18. The Top 10 and 5 Players Market Share by Liraglutide Injection Revenue in 2019
Figure 19. Liraglutide Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Liraglutide Injection Sales Market Share by Type (2015-2020)
Figure 21. Global Liraglutide Injection Sales Market Share by Type in 2019
Figure 22. Global Liraglutide Injection Revenue Market Share by Type (2015-2020)
Figure 23. Global Liraglutide Injection Revenue Market Share by Type in 2019
Figure 24. Global Liraglutide Injection Market Share by Price Range (2015-2020)
Figure 25. Global Liraglutide Injection Sales Market Share by Application (2015-2020)
Figure 26. Global Liraglutide Injection Sales Market Share by Application in 2019
Figure 27. Global Liraglutide Injection Revenue Market Share by Application (2015-2020)
Figure 28. Global Liraglutide Injection Revenue Market Share by Application in 2019
Figure 29. North America Liraglutide Injection Sales Growth Rate 2015-2020 (K Pcs)
Figure 30. North America Liraglutide Injection Revenue Growth Rate 2015-2020 (US$ Million)
Figure 31. North America Liraglutide Injection Sales Market Share by Country in 2019
Figure 32. North America Liraglutide Injection Revenue Market Share by Country in 2019
Figure 33. U.S. Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 34. U.S. Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Canada Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 36. Canada Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. North America Liraglutide Injection Market Share by Type in 2019
Figure 38. North America Liraglutide Injection Market Share by Application in 2019
Figure 39. Europe Liraglutide Injection Sales Growth Rate 2015-2020 (K Pcs)
Figure 40. Europe Liraglutide Injection Revenue Growth Rate 2015-2020 (US$ Million)
Figure 41. Europe Liraglutide Injection Sales Market Share by Country in 2019
Figure 42. Europe Liraglutide Injection Revenue Market Share by Country in 2019
Figure 43. Germany Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 44. Germany Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. France Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 46. France Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. U.K. Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 48. U.K. Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Italy Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 50. Italy Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Russia Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 52. Russia Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Europe Liraglutide Injection Market Share by Type in 2019
Figure 54. Europe Liraglutide Injection Market Share by Application in 2019
Figure 55. Asia Pacific Liraglutide Injection Sales Growth Rate 2015-2020 (K Pcs)
Figure 56. Asia Pacific Liraglutide Injection Revenue Growth Rate 2015-2020 (US$ Million)
Figure 57. Asia Pacific Liraglutide Injection Sales Market Share by Region in 2019
Figure 58. Asia Pacific Liraglutide Injection Revenue Market Share by Region in 2019
Figure 59. China Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 60. China Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Japan Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 62. Japan Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. South Korea Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 64. South Korea Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. India Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 66. India Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Australia Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 68. Australia Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Taiwan Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 70. Taiwan Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Indonesia Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 72. Indonesia Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Thailand Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 74. Thailand Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Malaysia Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 76. Malaysia Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Philippines Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 78. Philippines Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Vietnam Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 80. Vietnam Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Asia Pacific Liraglutide Injection Market Share by Type in 2019
Figure 82. Asia Pacific Liraglutide Injection Market Share by Application in 2019
Figure 83. Latin America Liraglutide Injection Sales Growth Rate 2015-2020 (K Pcs)
Figure 84. Latin America Liraglutide Injection Revenue Growth Rate 2015-2020 (US$ Million)
Figure 85. Latin America Liraglutide Injection Sales Market Share by Country in 2019
Figure 86. Latin America Liraglutide Injection Revenue Market Share by Country in 2019
Figure 87. Mexico Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 88. Mexico Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Brazil Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 90. Brazil Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Argentina Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 92. Argentina Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Latin America Liraglutide Injection Market Share by Type in 2019
Figure 94. Latin America Liraglutide Injection Market Share by Application in 2019
Figure 95. Middle East and Africa Liraglutide Injection Sales Growth Rate 2015-2020 (K Pcs)
Figure 96. Middle East and Africa Liraglutide Injection Revenue Growth Rate 2015-2020 (US$ Million)
Figure 97. Middle East and Africa Liraglutide Injection Sales Market Share by Country in 2019
Figure 98. Middle East and Africa Liraglutide Injection Revenue Market Share by Country in 2019
Figure 99. Turkey Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 100. Turkey Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 101. Saudi Arabia Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 102. Saudi Arabia Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. U.A.E Liraglutide Injection Sales Growth Rate (2015-2020) (K Pcs)
Figure 104. U.A.E Liraglutide Injection Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Middle East and Africa Liraglutide Injection Market Share by Type in 2019
Figure 106. Middle East and Africa Liraglutide Injection Market Share by Application in 2019
Figure 107. North America Liraglutide Injection Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 108. North America Liraglutide Injection Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 109. Europe Liraglutide Injection Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 110. Europe Liraglutide Injection Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Asia Pacific Liraglutide Injection Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 112. Asia Pacific Liraglutide Injection Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Latin America Liraglutide Injection Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 114. Latin America Liraglutide Injection Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Middle East and Africa Liraglutide Injection Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 116. Middle East and Africa Liraglutide Injection Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Porter's Five Forces Analysis
Figure 118. Channels of Distribution
Figure 119. Distributors Profiles
Figure 120. Bottom-up and Top-down Approaches for This Report
Figure 121. Data Triangulation
Figure 122. Key Executives Interviewed